Financial statements Prologis Poland Xxv
Balance sheet data of PROLOGIS POLAND XXV
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 21 473 702,60 | 20 290 143,58 | 19 341 011,30 | 19 183 084,67 | 18 454 493,01 | 17 419 604,53 |
| A. Fixed assets | 20 288 380,82 | 19 344 511,92 | 18 556 492,82 | 18 172 729,27 | 17 316 007,71 | 16 616 253,52 |
| B. Current assets | 1 185 321,78 | 945 631,66 | 784 518,48 | 1 010 355,40 | 1 138 485,30 | 803 351,01 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 21 473 702,60 | 20 290 143,58 | 19 341 011,30 | 19 183 084,67 | 18 454 493,01 | 17 419 604,53 |
| A. Equity | -8 175 386,26 | -8 623 572,25 | -10 556 896,13 | -9 971 780,68 | -10 141 568,06 | -9 330 530,90 |
| B. Liabilities and provisions for liabilities | 29 649 088,86 | 28 913 715,83 | 29 897 907,43 | 29 154 865,35 | 28 596 061,07 | 26 750 135,43 |
| I. Long-term liabilities | 29 019 718,12 | 28 290 324,61 | 29 227 869,14 | 27 373 418,17 | 26 433 389,01 | 25 308 375,41 |
| II. Short-term liabilities | 334 426,77 | 303 696,10 | 340 732,12 | 1 446 705,21 | 1 732 147,17 | 1 371 002,20 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.